Last 12 months
Inside the activity.
0 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 8 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2021 Filed Feb 25, 2021 21:24 UTC |
Jacobsmeyer Barbara AnnPresident, Inpatient Hospitals
|
GrantEncompass Health Common Stock | 7,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007892 · form4.xml · nonDerivative · entry 2 Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,911 F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 21, 2019 Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:23 UTC |
Fay EdmundSr. Vice Pres. and Treasurer
|
GrantEncompass Health Common Stock | 1,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007889 · form4.xml · nonDerivative · entry 3 Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,947 F3 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:23 UTC |
Fay EdmundSr. Vice Pres. and Treasurer
|
GrantEncompass Health Common Stock | 2,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007889 · form4.xml · nonDerivative · entry 2 Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,248 F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 21, 2019 Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:21 UTC |
Darby John PatrickEVP, Gen Counsel & Secretary
|
GrantEncompass Health Common Stock | 2,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007888 · form4.xml · nonDerivative · entry 3 Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,914 F3 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:21 UTC |
Darby John PatrickEVP, Gen Counsel & Secretary
|
GrantEncompass Health Common Stock | 5,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007888 · form4.xml · nonDerivative · entry 2 Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,690 F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 21, 2019 Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:15 UTC |
Charbonneau Elissa JoyChief Medical Officer
|
GrantEncompass Health Common Stock | 2,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007884 · form4.xml · nonDerivative · entry 3 Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,353.061 F3 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:15 UTC |
Charbonneau Elissa JoyChief Medical Officer
|
GrantEncompass Health Common Stock | 2,485 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007884 · form4.xml · nonDerivative · entry 2 Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,331.061 F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 21, 2019 Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:20 UTC |
COLTHARP DOUGLAS EEVP & Chief Financial Officer
|
GrantEncompass Health Common Stock | 4,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007887 · form4.xml · nonDerivative · entry 3 COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,249 F3 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:20 UTC |
COLTHARP DOUGLAS EEVP & Chief Financial Officer
|
GrantEncompass Health Common Stock | 9,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007887 · form4.xml · nonDerivative · entry 2 COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,532 F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 21, 2019 Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:13 UTC |
Anthony April Kaye BullockCEO & President, Home Health
|
GrantEncompass Health Common Stock | 2,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007882 · form4.xml · nonDerivative · entry 2 Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,066 F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:13 UTC |
Anthony April Kaye BullockCEO & President, Home Health
|
GrantEncompass Health Common Stock | 3,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007882 · form4.xml · nonDerivative · entry 1 Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,842 F1 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 21, 2019 Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:27 UTC |
Tarr Mark JDirector · President & CEO
|
Tax withholdingEncompass Health Common Stock | 1,975 | $80.23 | $158,454.25 |
DisclosureSEC source: 0001127602-21-007895 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,414 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:26 UTC |
Price Andrew LChief Accounting Officer
|
Tax withholdingEncompass Health Common Stock | 314 | $80.23 | $25,192.22 |
DisclosureSEC source: 0001127602-21-007894 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,337 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:24 UTC |
Jacobsmeyer Barbara AnnPresident, Inpatient Hospitals
|
Tax withholdingEncompass Health Common Stock | 466 | $80.23 | $37,387.18 |
DisclosureSEC source: 0001127602-21-007892 · form4.xml · nonDerivative · entry 1 Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,375 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:23 UTC |
Fay EdmundSr. Vice Pres. and Treasurer
|
Tax withholdingEncompass Health Common Stock | 312 | $80.23 | $25,031.76 |
DisclosureSEC source: 0001127602-21-007889 · form4.xml · nonDerivative · entry 1 Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,160 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:21 UTC |
Darby John PatrickEVP, Gen Counsel & Secretary
|
Tax withholdingEncompass Health Common Stock | 401 | $80.23 | $32,172.23 |
DisclosureSEC source: 0001127602-21-007888 · form4.xml · nonDerivative · entry 1 Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,224 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:15 UTC |
Charbonneau Elissa JoyChief Medical Officer
|
Tax withholdingEncompass Health Common Stock | 356 | $80.23 | $28,561.88 |
DisclosureSEC source: 0001127602-21-007884 · form4.xml · nonDerivative · entry 1 Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,846.061 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:20 UTC |
COLTHARP DOUGLAS EEVP & Chief Financial Officer
|
Tax withholdingEncompass Health Common Stock | 790 | $80.23 | $63,381.70 |
DisclosureSEC source: 0001127602-21-007887 · form4.xml · nonDerivative · entry 1 COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,257 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 22:59 UTC |
COLTHARP DOUGLAS EEVP & Chief Financial Officer
|
Tax withholdingEncompass Health Common Stock | 621 | $80.51 | $49,996.71 |
DisclosureSEC source: 0001127602-21-007392 · form4.xml · nonDerivative · entry 2 COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,047 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 22:18 UTC |
Tarr Mark JDirector · President & CEO
|
Tax withholdingEncompass Health Common Stock | 2,039 | $80.51 | $164,159.89 |
DisclosureSEC source: 0001127602-21-007370 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,389 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 22:17 UTC |
Price Andrew LChief Accounting Officer
|
Tax withholdingEncompass Health Common Stock | 277 | $80.51 | $22,301.27 |
DisclosureSEC source: 0001127602-21-007369 · form4.xml · nonDerivative · entry 2 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,651 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 22:16 UTC |
Jacobsmeyer Barbara AnnPresident, Inpatient Hospitals
|
Tax withholdingEncompass Health Common Stock | 505 | $80.51 | $40,657.55 |
DisclosureSEC source: 0001127602-21-007368 · form4.xml · nonDerivative · entry 2 Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,841 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 22:14 UTC |
Fay EdmundSr. Vice Pres. and Treasurer
|
Tax withholdingEncompass Health Common Stock | 275 | $80.51 | $22,140.25 |
DisclosureSEC source: 0001127602-21-007367 · form4.xml · nonDerivative · entry 2 Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,472 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 22:13 UTC |
Darby John PatrickEVP, Gen Counsel & Secretary
|
Tax withholdingEncompass Health Common Stock | 366 | $80.51 | $29,466.66 |
DisclosureSEC source: 0001127602-21-007366 · form4.xml · nonDerivative · entry 2 Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,625 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 22:12 UTC |
Charbonneau Elissa JoyChief Medical Officer
|
Tax withholdingEncompass Health Common Stock | 328 | $80.51 | $26,407.28 |
DisclosureSEC source: 0001127602-21-007365 · form4.xml · nonDerivative · entry 2 Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,202.061 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 22:11 UTC |
Anthony April Kaye BullockCEO & President, Home Health
|
Tax withholdingEncompass Health Common Stock | 142 | $80.51 | $11,432.42 |
DisclosureSEC source: 0001127602-21-007364 · form4.xml · nonDerivative · entry 2 Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,393 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 22:59 UTC |
COLTHARP DOUGLAS EEVP & Chief Financial Officer
|
Tax withholdingEncompass Health Common Stock | 650 | $80.51 | $52,331.50 |
DisclosureSEC source: 0001127602-21-007392 · form4.xml · nonDerivative · entry 1 COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,668 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 22:18 UTC |
Tarr Mark JDirector · President & CEO
|
Tax withholdingEncompass Health Common Stock | 1,743 | $80.51 | $140,328.93 |
DisclosureSEC source: 0001127602-21-007370 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,428 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 22:17 UTC |
Price Andrew LChief Accounting Officer
|
Tax withholdingEncompass Health Common Stock | 247 | $80.51 | $19,885.97 |
DisclosureSEC source: 0001127602-21-007369 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,928 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 22:16 UTC |
Jacobsmeyer Barbara AnnPresident, Inpatient Hospitals
|
Tax withholdingEncompass Health Common Stock | 543 | $80.51 | $43,716.93 |
DisclosureSEC source: 0001127602-21-007368 · form4.xml · nonDerivative · entry 1 Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,346 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 22:14 UTC |
Fay EdmundSr. Vice Pres. and Treasurer
|
Tax withholdingEncompass Health Common Stock | 231 | $80.51 | $18,597.81 |
DisclosureSEC source: 0001127602-21-007367 · form4.xml · nonDerivative · entry 1 Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,747 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 22:13 UTC |
Darby John PatrickEVP, Gen Counsel & Secretary
|
Tax withholdingEncompass Health Common Stock | 305 | $80.51 | $24,555.55 |
DisclosureSEC source: 0001127602-21-007366 · form4.xml · nonDerivative · entry 1 Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,991 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 22:12 UTC |
Charbonneau Elissa JoyChief Medical Officer
|
Tax withholdingEncompass Health Common Stock | 275 | $80.51 | $22,140.25 |
DisclosureSEC source: 0001127602-21-007365 · form4.xml · nonDerivative · entry 1 Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,530.061 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 22:11 UTC |
Anthony April Kaye BullockCEO & President, Home Health
|
Tax withholdingEncompass Health Common Stock | 205 | $80.51 | $16,504.55 |
DisclosureSEC source: 0001127602-21-007364 · form4.xml · nonDerivative · entry 1 Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,535 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:44 UTC |
Williams TerranceDirector
|
GrantEncompass Health Common Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002094 · form4.xml · nonDerivative · entry 1 Williams Terrance · CIK 0001798480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,097 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:43 UTC |
SHAW L EDWARD JRDirector
|
GrantEncompass Health Common Stock | 49 | $83.22 | $4,077.78 |
DisclosureSEC source: 0001127602-21-002093 · form4.xml · nonDerivative · entry 2 SHAW L EDWARD JR · CIK 0001183337 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,871 F2 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On January 15, 2021, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:43 UTC |
SHAW L EDWARD JRDirector
|
GrantEncompass Health Common Stock | 244 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002093 · form4.xml · nonDerivative · entry 1 SHAW L EDWARD JR · CIK 0001183337 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,822 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:41 UTC |
SCHLICHTING NANCY MDirector
|
GrantEncompass Health Common Stock | 28 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002092 · form4.xml · nonDerivative · entry 1 SCHLICHTING NANCY M · CIK 0001376358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,173 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:40 UTC |
MAUPIN JOHN E JR D D SDirector
|
GrantEncompass Health Common Stock | 5 | $83.11 | $415.55 |
DisclosureSEC source: 0001127602-21-002091 · form4.xml · nonDerivative · entry 2 MAUPIN JOHN E JR D D S · CIK 0001189149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,005 F2 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On January 15, 2021, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:40 UTC |
MAUPIN JOHN E JR D D SDirector
|
GrantEncompass Health Common Stock | 244 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002091 · form4.xml · nonDerivative · entry 1 MAUPIN JOHN E JR D D S · CIK 0001189149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:38 UTC |
Maryland Patricia AnneDirector
|
GrantEncompass Health Common Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002090 · form4.xml · nonDerivative · entry 1 Maryland Patricia Anne · CIK 0001798468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,097 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:37 UTC |
KATZ LESLYE GDirector
|
GrantEncompass Health Common Stock | 95 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002089 · form4.xml · nonDerivative · entry 1 KATZ LESLYE G · CIK 0001193884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,295 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:36 UTC |
HIGDON LEO I JRDirector
|
GrantEncompass Health Common Stock | 244 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002088 · form4.xml · nonDerivative · entry 1 HIGDON LEO I JR · CIK 0001064587 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,172 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:35 UTC |
HERMAN JOAN EDirector
|
GrantEncompass Health Common Stock | 95 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002087 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,295 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:35 UTC |
ELSON CHARLES MDirector
|
GrantEncompass Health Common Stock | 244 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002086 · form4.xml · nonDerivative · entry 1 ELSON CHARLES M · CIK 0001122124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,762 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:33 UTC |
CURL YVONNE MDirector
|
GrantEncompass Health Common Stock | 244 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002085 · form4.xml · nonDerivative · entry 1 CURL YVONNE M · CIK 0001135567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,239 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:32 UTC |
CORRELL DONALD LDirector
|
GrantEncompass Health Common Stock | 244 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002084 · form4.xml · nonDerivative · entry 1 CORRELL DONALD L · CIK 0001199794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,002 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:31 UTC |
CHIDSEY JOHNDirector
|
GrantEncompass Health Common Stock | 172 | $83.26 | $14,320.72 |
DisclosureSEC source: 0001127602-21-002083 · form4.xml · nonDerivative · entry 2 CHIDSEY JOHN · CIK 0001128484 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,118 F2 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On January 15, 2021, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:31 UTC |
CHIDSEY JOHNDirector
|
GrantEncompass Health Common Stock | 233 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002083 · form4.xml · nonDerivative · entry 1 CHIDSEY JOHN · CIK 0001128484 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,946 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:30 UTC |
CARMICHAEL GREG DDirector
|
GrantEncompass Health Common Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002082 · form4.xml · nonDerivative · entry 1 CARMICHAEL GREG D · CIK 0001247734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,097 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.